You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Mitomycin C treatment for advanced gallbladder carcinoma showed limited efficacy, with stationary disease in some patients but also progressive disease and treatment failures. Median survival was 4 months, with significant toxicities like thrombocytopenia observed.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: